PlasFree is a private medical device company founded in 2017.
We focus on the development of an innovative medical device ClearPlasma™ that modifies human plasma to improve treatment for massive bleeding.
ClearPlasma™ effectively and specifically extracts Fibrinolytic proteins that are responsible for dissolving blood clots. By doing so, ClearPlasma™ modifies the human plasma generating improved plasma that is more prone to coagulation.
Thus, our product aims to revolutionize the treatment of massive bleeding and to enable safe and effective treatment to massive bleeding around the world.